Release Date: February 05, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Have you worked through the higher cost NHPs, and what are the current ordering patterns from customers? A: (CEO) We have worked through all the higher cost NHPs. Ordering patterns have stabilized, and we have more solid commitments for this year compared to last year. We anticipate more consistent revenue streams with reduced volatility.
Q: How could the potential halt of NHP exports from Cambodia impact the global supply and demand dynamics? A: (CEO) Cambodia is a significant part of the global supply base. If exports stop, it will pressure other supply bases. We are prepared for either scenario and have diversified our supply sources to mitigate risks.
Q: Can you provide guidance on adjusted EBITDA expectations for the fiscal year? A: (CEO) While not providing specific guidance, we expect year-over-year sales growth and improved margins as we progress through the year. We are ahead of our original covenant expectations and anticipate positive EBITDA growth.
Q: Did any NHP sales slip from Q1 into Q2, and how does this affect revenue? A: (CEO) Yes, some sales slipped into Q2, which can shift revenue by a few million dollars. However, this is a short-term shift, and we expect less volatility compared to last year.
Q: What is the impact of cancellations on your book-to-bill ratio, and what caused the recent increase in cancellations? A: (CEO) We had a significant $4 million project cancellation, which impacted the book-to-bill ratio. This was an anomaly, and we are seeing positive trends in new awards, particularly in discovery services.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。